DeRubeis, Ph.D., from the University of Pennsylvania, Philadelphia, and co-workers compared the efficacy of antidepressant medicines with cognitive therapy in 240 moderately to severely depressed patients. Study individuals were randomly assigned to get antidepressant medication , pill placebo , or cognitive therapy . Those in the medicine group were given placebo or paroxetine for eight weeks, with doses increasing as tolerated.‘Fostering research and research excellence can be an important worth and a key component of our technique. We therefore continue steadily to provide Boehringer Ingelheim FENS Analysis Award – today for the fourth period – and therewith support the advancement of exceptional young scientists’, stated Dr Manfred Haehl, Corporate Senior Vice President Medication Boehringer Ingelheim. The speech to honour Dr Fries was shipped by PD Dr Pico Caroni from the Friedrich-Miescher-Institute in Basel and person in the local arranging committee. About Boehringer Ingelheim The Boehringer Ingelheim group is among the world’s 20 leading pharmaceutical businesses. Headquartered in Ingelheim, Germany, it operates with 135 affiliates in 47 countries and 39 globally,800 employees.